Flizasertib
Flizasertib is a serine/threonine kinase inhibitor[1].
Product Specifications
CAS Number
2268739-68-8
Product Name Alternative
GDC-8264
UNSPSC
12352005
Target
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/flizasertib.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
F[C@@H]1C2=NC(C(C3CC3)=O)=NN2[C@H](C4=CC=CC=C4)C1
Molecular Formula
C15H14FN3O
Molecular Weight
271.29
References & Citations
[1]WHO Drug Information-World Health Organization (WHO) .
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042983-100 1x 100 µL
Neurofilament (NF-L) (Neuronal Marker) (NEFL/2983R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC473185-100 1x 100 µL
Adipophilin / Perilipin-2 (Marker of Lipid Accumulation) (rADFP/1493), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402075-100 1x 100 µL
MyoD1 (Rhabdomyosarcoma Marker) (MYOD1/2075R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
